Vakils provides powerful solutions and flawless execution in order to unlock the productivity and efficiency within our clients’ marketing communications operations.
We are a company that dates back to 1946, with the founding of our parent company Vakil & Sons. The entrepreneurial and visionary spirit of Vakils & Sons transformed the designing and printing industry in India. Continuing this pioneering spirit of adaptation and innovation, Vakils Premedia was incorporated in 2004 to meet the needs of specialised premedia and digital offerings.
Today, Vakils provides powerful solutions and flawless execution, In order to unlock the productivity and efficiency within our clients’ marketing communication operations. We value building in-depth relationships with our clients and always make their needs the priority.
Vakils brings the experience of working across Europe, Asia Pacific, Australia, Latin America and the United States. We are the preferred partner to companies such as J&J, Ferring Pharmaceuticals, Santen Pharma and Kyowa Kirin.
Vakils’ team of specialists undergo continuous training on information asset protection policies, good manufacturing practices and standard operating procedures. This enables them to create pharmaceutical artwork, which is compliant and of the finest quality.
We bring the experience of working across Europe, Asia Pacific, Australia, Latin America and the United States. We are the preferred partner to companies such as Aurobindo Pharma, Kyowa Kirin and Janssen Pharmaceuticals.
Vakils is an ISO 27001:2013 and ISO 9001:2015 certified company.
Specialised Expertise For Global Markets
The global nature of pharmaceutical supply chains means that companies must comply with localisation as per language, cultural and regulatory requirements. Vakils has the experience and expertise in developing fully compliant branding designs, as per local regulatory requirements and current manufacturing guidelines, in various languages for multiple markets.
We enable pharmaceutical and life science companies to differentiate themselves by reducing time to market, delivering quick product mixes and swiftly responding to market needs.
Globalisation and Localisation
We have the experience and expertise in developing fully compliant designs of new and existing branding designs for multiple markets, in various languages.
Multi-language Pharmaceutical Artwork
Vakils’ multi-language artwork services help clients manage the complexities of foreign languages. Our expertise ensures multi-language updates are implemented correctly for new artwork and amendments.
Quality check on primary labelling documents such as:
- CCDS : Company Core Data Sheet
- USPI : United States Prescribing Information
- EUPI: European Product Information
Secondary documents such as:
- CPPI : Company Patient Product Information
- IFU : Instruction for Use
- PI : Patient Information
- Medication Guide/li>
About Pharma and Device Packaging and Labelling Forum 2023
Packaging innovation has had to accelerate at a faster rate than ever before in recent years to optimize drug delivery for pharma, healthcare professionals, and patients alike – but it's necessary to keep up with medical advances, stay ahead of competition, and accommodate the unique and differentiated needs of combination products, biologics, vaccines, and other specialty medicines.
We are inviting you to be a part of WORLD BI’s Pharma & Device Packaging and Labelling Forum 2023 to meet with the industry experts and visionaries from around the world to deliberate over the latest innovations & explore the growing opportunities in the Pharma packaging Industry.
The forum will deliver senior-level executive insights, unrivalled networking and knowledge sharing opportunities with high-value actionable content on multiple facets of the industry. Speakers from notable pharma and medical device companies like Medtronic, Aurobindo Pharma Limited, Novartis, ESKO, Gradient, Metsä Board, Takeda, Boehringer Ingelheim España, S.A, Abdi İbrahim Pharmaceuticals, Sandoz, GENSENTA İLAÇ, CEPI, Lucerne University of Applied Sciences and Arts, Bushu Pharmaceuticals Ltd and many more will be joining and sharing their valuable insights.